Atlas Trials

Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma

Clinical trial NCT02282917 · TERMINATED

Trial details

NCT number
NCT02282917
Sponsor
Massachusetts Eye and Ear Infirmary
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Vestibular SchwannomaMeningiomaAcoustic NeuromaNeurofibromatosis Type 2
Start date
2015-12-01
Primary completion
2017-05-30
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.